European Healthtech startup funding raised during 2015.
In 2015, 218 European Healthtech companies raised a combined €1.9B across 235 funding rounds. Switzerland led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 6 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| CureVac | Series D+ | Oct 2015 | €100M |
| CeQur | Series C | Aug 2015 | €89M |
| Benevolent | Growth/Late | Jul 2015 | €80M |
| Merus | Series C | Jul 2015 | €73M |
| ADC Therapeutics |
| Growth/Late |
| Aug 2015 |
| €71M |
| Symphogen | Debt | Sep 2015 | €68M |
| CRISPR Therapeutics | Series B | Mar 2015 | €59M |
| ObsEva | Series B | Oct 2015 | €54M |
| CureVac | Series D+ | Feb 2015 | €46M |
| Kymab | Series B | Apr 2015 | €45M |
| Sanifit | Series C | Aug 2015 | €37M |
| DNAe LTD | Debt | Oct 2015 | €35M |
| Bima | Series C | Jun 2015 | €34M |
| GenSight Biologics | Series B | Jun 2015 | €32M |
| NightstaRx | Series B | Oct 2015 | €32M |
